Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation

被引:60
作者
Burashnikov, Alexander [1 ]
Petroski, Alyssa [1 ]
Hu, Dan [1 ]
Barajas-Martinez, Hector [1 ]
Antzelevitch, Charles [1 ]
机构
[1] Masonic Med Res Lab, Utica, NY 13501 USA
关键词
Antiarrhythmic drugs; Atrial fibrillation; Arrhythmias; Electrophysiology; Pharmacology; CHRONIC AMIODARONE; RANOLAZINE; COMBINATION; BLOCK;
D O I
10.1016/j.hrthm.2011.08.027
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
BACKGROUND Wenxin Keli is a Chinese herb extract reported to be of benefit in the treatment of cardiac arrhythmias, cardiac inflammation, and heart failure. METHODS AND RESULTS We evaluated the electrophysiologic effects of Wenxin Keli in isolated canine arterially perfused right atrial preparations with a rim of right ventricular tissue (n = 11). Transmembrane action potentials and a pseudoelectrocardiogram were simultaneously recorded. Acetylcholine (1 mu M) was used to induce atrial fibrillation (AF) and to test the anti-AF potential of Wenxin Keli (5 g/L). Wenxin Keli produced preferential abbreviation of action potential duration measured at 90% repolarization (APD(90)) in atria, but caused atrial-selective prolongation of the effective refractory period, due to the development of postrepolarization refractoriness. The maximum rate of rise of the action potential upstroke was preferentially reduced in atria. The diastolic threshold of excitation increased in both atria and ventricles, but much more in atria. The duration of the "P wave" (index of atrial conduction time) was prolonged to a much greater extent than the duration of the "QRS complex" (index of ventricular conduction time). Wenxin Keli significantly reduced I-Na and shifted steady-state inactivation to more negative potentials in HEK293 cells stably expressing SCN5A. Wenxin Keli prevented the induction of persistent AF in 100% atria (6/6) and, in another experimental series, was found to terminate persistent acetylcholine-mediated AF in 100% of atria (3/3). CONCLUSION Wenxin Keli produces atrial-selective depression of INa-dependent parameters in canine isolated coronary-perfused preparations via a unique mechanism and is effective in suppressing AF and preventing its induction, with minimal effects on the ventricular electrophysiology.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 31 条
[1]
Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation [J].
Antzelevitch, Charles ;
Burashnikov, Alexander .
JOURNAL OF ELECTROCARDIOLOGY, 2009, 42 (06) :543-548
[2]
Role of repolarization restitution in the development of coarse and fine atrial fibrillation in the isolated canine right atria [J].
Burashnikov, A ;
Antzelevitch, C .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16 (06) :639-645
[3]
Can inhibition of IKur promote atrial fibrillation? [J].
Burashnikov, Alexander ;
Antzelevitch, Charles .
HEART RHYTHM, 2008, 5 (09) :1304-1309
[4]
Atrial-selective sodium channel blockers: Do they exist? [J].
Burashnikov, Alexander ;
Antzelevitch, Charles .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 52 (02) :121-128
[5]
Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation - Differences in sodium channel inactivation between atria and ventricles and the role of ranolazine [J].
Burashnikov, Alexander ;
Di Diego, Jose M. ;
Zygmunt, Andrew C. ;
Belardinelli, Luiz ;
Antzelevitch, Charles .
CIRCULATION, 2007, 116 (13) :1449-1457
[6]
Synergistic Effect of the Combination of Ranolazine and Dronedarone to Suppress Atrial Fibrillation [J].
Burashnikov, Alexander ;
Sicouri, Serge ;
Di Diego, Jose M. ;
Belardinelli, Luiz ;
Antzelevitch, Charles .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (15) :1216-1224
[7]
AZD1305 Exerts Atrial Predominant Electrophysiological Actions and Is Effective in Suppressing Atrial Fibrillation and Preventing Its Reinduction in the Dog [J].
Burashnikov, Alexander ;
Zygmunt, Andrew C. ;
Di Diego, Jose M. ;
Linhardt, Gunilla ;
Carlsson, Leif ;
Antzelevitch, Charles .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 56 (01) :80-90
[8]
New developments in atrial antiarrhythmic drug therapy [J].
Burashnikov, Alexander ;
Antzelevitch, Charles .
NATURE REVIEWS CARDIOLOGY, 2010, 7 (03) :139-148
[9]
Atrial-selective sodium channel block for the treatment of atrial fibrillation [J].
Burashnikov, Alexander ;
Antzelevitch, Charles .
EXPERT OPINION ON EMERGING DRUGS, 2009, 14 (02) :233-249
[10]
Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation [J].
Burashnikov, Alexander ;
Di Diego, Jose M. ;
Sicouri, Serge ;
Ferreiro, Marceta ;
Carlsson, Leif ;
Antzeevitch, Charles .
HEART RHYTHM, 2008, 5 (12) :1735-1742